AstraZeneca Group (AZN)

47.16 -0.33  -0.69%  Feb 10, 11:00PM Go Pro
Watch
View Full Chart AZN Price Chart

Key Stats

Market Cap 63.44B
Revenue Growth 3.99%
Profit Margin 42.34%
Earnings Yield 15.46%
Dividend Yield 8.20%
Earnings Per Share TTM 7.29
PE Ratio 6.47
Price / Sales Ratio 1.89
52 Week High 52.54
52 Week Low 40.89
Beta 0.60
View Pro Ratings Details

YCharts Pro Ratings

Go Pro.
Learn More
  • Pro Value Score Go Pro
  • Pro Fundamental Score Go Pro
  • Pro Valuation from Historical Multiples Go Pro

News

Feb 10 1 Biotech to Buy Post-Plunge Fool
Feb 09 [$$] Pharma Looks Ready to Turn Defense Into Offense
Feb 09 AstraZeneca (AZN) Lower, Loses Certain CRESTOR Patent Decision Street Insider
Feb 09 5 Pharmaceutical Stocks To Consider Now
Feb 08 U.K. Mega Caps Earnings And Dividend Update
Feb 08 Anticipation
Feb 08 Can The Man From Heinz Keep Novartis On Top?
Feb 08 Eurodebt Woes for the European Drug Sector
Feb 08 Higher Bleeding Haunts Merck Candidate
Feb 08 Higher Bleeding Haunts Merck Candidate - Analyst Blog Zacks
Feb 08 Stocks trading ex-dividend one week from today: http://stks.co/2Ijt / $V $CVX $WAG $WLT $MCO $AZN $BRCM $LLTC $ROST ... by DynamicDividend
Feb 02 Today's top business news http://stks.co/2Dii #cdnecon #cdnpoli #eurozone #greece #econ $PTR $RDS.B $FB $AZN $JNJ $SNY $MRK $OTEX $OTC.CA by michaelbabad
Feb 02 RT @bradloncar Not impressed w big share buyback $AZN is planning for 2012. Won't help investrs much if they dont figure out innovation soon by wallstreetbean
Feb 02 Top business stories at midday http://stks.co/2DR2 #eurozone #econ $PTR $RDS.B $FB $AZN $JNJ $SNY $MRK $OTEX $OTC.CA by michaelbabad
Feb 02 R&D in Quebec pharma industry continues to erode $AZN $JNJ $SNY $MRK by michaelbabad

Profile

Exchange: NYSE       Sector: Healthcare       Industry: Drug Manufacturers - Major

AstraZeneca plc is a global pharmaceutical and biologics company headquartered in London, United Kingdom. It is the world's seventh-largest pharmaceutical company measured by revenues and has operations in over 100 countries. It has a portfolio of products for major disease areas including cancer, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and inflammation. AstraZeneca PLC markets its products primarily to primary care and specialist doctors, and other healthcare professionals through distributors or local representative offices. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was founded in 1992.

1 Year Total Return Performance

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). AstraZeneca Group is down N/A over the last year vs S&P 500 Total Return up N/A, Merck up N/A, and Pfizer up N/A.

  • AZN Total Returns
  • ^SPXTR Total Returns
  • MRK Total Returns
  • PFE Total Returns

Fundamentals

Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.

Income Statement View Statement

Get Quote for

Pro Strategies Featuring AZN

Did AstraZeneca Group make it into our Pro Portfolio Strategies?

Start your YCharts Pro membership now to find out.

AZN Related Topics

AZN Charts

Recent Quotes

Symbol Price Chg Chg % Market Cap
AZN 47.16 -0.33 -0.69% 63.44B
ECA 18.98 -0.37 -1.91% 13.97B
IPG 10.73 -0.08 -0.74% 5.13B
BNX 0.04 -0.01 -15.80% 1.09M
IHG 21.93 0.07 0.32% 6.37B
ENA 0.37 -0.02 -5.13% 11.66M
MGT 0.06 0.00 2.04% 2.18M
AEN 2.71 0.02 0.74% 76.10M
BDX 76.42 -0.43 -0.56% 16.32B
SFL 11.65 -0.37 -3.08% 921.86M
You must be signed in to use watchlists.
Sign In or Register
Create Watchlist from Stock Quotes
Close